Market Tracker

04/27 8:44am ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.69
Delayed Data
As of Apr 26
 -0.0283 / -3.94%
Today’s Change
0.39
Today|||52-Week Range
2.64
+0.03%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.72
Today’s open0.67
Day’s range0.65 - 0.73
Volume409,518
Average volume (3 months)274,287
Market cap$18.1M
Dividend yield--
Data as of 04/26/2017

Growth & Valuation

Earnings growth (last year)+52.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-30.83%
P/E ratioNM
Price/Sales163.59
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc+0.00+0.38%
ARGSArgos Therapeutics I...-0.04-7.58%
OGENOragenics Inc+0.07+22.54%
ACSTAcasti Pharma Inc+0.01+0.78%
Data as of 04/26/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$92.0K
Annual profit (last year)-$7.5M
Net profit margin-8,154.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Vice Chairman
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts